Amyloidoma and Plasmacytoma Presented as a Solitary Lung Nodule in a Patient of Multiple Myeloma With AL-Amyloidosis: A Case Report and Review of Literature

被引:1
作者
Yadav, Ruchi [1 ,3 ]
Sun, Lishi [1 ]
Cheema, Akhtar [1 ]
Yadav, Vivek [2 ]
Wang, Jen Chin [1 ]
机构
[1] Brookdale Univ, Hosp Med Ctr, Brooklyn, NY 11212 USA
[2] SUNY Downstate Hlth Sci Univ, Brooklyn, NY USA
[3] Brookdale Univ, Hosp Med Ctr, Dept Internal Med, One Brookdale Plaza, Brooklyn, NY 11212 USA
关键词
amyloidoma; plasmacytoma; lung nodule; multiple myeloma; systemic AL-amyloidosis; PULMONARY AMYLOIDOSIS; CHAIN; DEXAMETHASONE; INVOLVEMENT; DIAGNOSIS;
D O I
10.1177/23247096231184768
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular amyloidoma in the lungs is a rare entity, also the occurrence of extramedullary plasmacytoma (EMP) in the lungs is rare. To have concomitant EMP and amyloidoma presented as a single lung mass is even rarer. There was only one similar case reported in the abstract form previously. Our case did not respond to many novel chemotherapy agents, suggesting that this combination of amyloidoma and plasmacytoma belonged to a poor prognosis entity, requiring different treatment modalities, such as early bone marrow transplantation or CART (chimeric antigen receptors T) therapy.
引用
收藏
页数:7
相关论文
共 36 条
[1]  
Andrei Mirela, 2019, Hematol Oncol Stem Cell Ther, V12, P71, DOI [10.1016/j.hemonc.2018.09.003, 10.1016/j.hemonc.2018.09.003]
[2]   Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? [J].
Bahlis, N. J. ;
Lazarus, H. M. .
BONE MARROW TRANSPLANTATION, 2006, 38 (01) :7-15
[3]  
Batsakis John G, 2002, Ann Diagn Pathol, V6, P129, DOI 10.1053/adpa.2002.33458
[4]   Extramedullary involvement in multiple myeloma [J].
Blade, Joan ;
Fernandez de Larrea, Carlos ;
Rosinol, Laura .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (11) :1618-1619
[5]  
Chaulagain CP, 2015, CLIN ADV HEMATOL ONC, V13, P315
[6]  
Cohen A, 2014, BLOOD, V124
[7]   Subcutaneous daratumumab (DARA SC) plus cyclophosphamide, bortezomib, and dexamethasone (CyBorD) in patients (Pts) with newly diagnosed amyloid light chain (AL) amyloidosis: Safety run-in results of andromeda. [J].
Comenzo, Ray ;
Kastritis, Efstathios ;
Maurer, Mathew ;
Zonder, Jeffrey A. ;
Minnema, Monique ;
Schonland, Stefan .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[8]   Pulmonary amyloidosis in hematological disorders [J].
Cordier, JF .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (05) :502-513
[9]   Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis [J].
Dispenzieri, A ;
Gertz, MA ;
Kyle, RA ;
Lacy, MQ ;
Burritt, MF ;
Therneau, TM ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Rajkumar, SV ;
Fonseca, R ;
Zeldenrust, SR ;
McGregor, CGA ;
Jaffe, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3751-3757
[10]  
Duggal RK., 2002, JIACM, V3, P93